US4087415A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Antithrombin III
Assignee: Individual
•
Filing: 1976-06-09
•
Granted: 1978-05-02
•
Expires: 1996-06-09
Abstract
Abstract High purity antithrombin III is recovered from a procedure in which the other protein fractions in human blood plasma are recovered for further processing. The protein fractions are recovered sequentially in separate steps: fibrinogen and Factor VIII are recovered as a precipitate; prothrombin complex is recovered on the surface of finely divided tricalcium phosphate; albumin and gamma globulin are recovered in an aqueous supernate; a protein precipitate containing lipids, lipoproteins and other trace protein contaminants is recovered; and antithrombin III is recovered as a precipitated phase. The fibrinogen, Factor VIII, prothrombin complex, albumin, gamma globulin and protein contaminants are all recovered in such a way that they are suitable for further processing.
Inventors
- 👤 Rodger L. Bick
- 👤 Lajos F. Fekete
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 10:48
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/81; C07K14/8107; C07K14/811; C07K14/8121; C07K14/8128; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/829; Y10S530/83; Y10S530/831
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
106 words
A process for recovering clinically usable antithrombin III comprising: (a) admixing a blood plasma fraction which is substantially free of fibrinogen, Factor VIII and prothrombin complex with aqueous aluminum hydroxide gel to adsorb crude antithrombin III on the gel; (b) treating the crude antithrombin III-containing aluminum hydroxide gel with a sodium phosphate solution containing an aluminum chelating agent to separate the crude antithrombin III in the supernate remaining therefrom; (c) treating said supernate with an ethylene oxide-propylene oxide block copolymer or polyethylene glycol protein precipitating agent to separate purified antithrombin III in the supernate remaining therefrom; and (d) separating and recovering the thus purified antithrombin III.
Claim 2
Dependent Claim
106 words
A process for recovering clinically usable antithrombin III comprising: (a) admixing a blood plasma fraction which is substantially free of fibrinogen, Factor VIII and prothrombin complex with aqueous aluminum hydroxide gel to adsorb crude antithrombin III on the gel; (b) treating the crude antithrombin III-containing aluminum hydroxide gel with a sodium phosphate solution containing an aluminum chelating agent to separate the crude antithrombin III in the supernate remaining therefrom; (c) treating said supernate with an ethylene oxide-propylene oxide block copolymer or polyethylene glycol protein precipitating agent to separate purified antithrombin III in the supernate remaining therefrom; and (d) separating and recovering the thus purified antithrombin III.
Claim 3
Dependent Claim
40 words
The process of claim 1, wherein the purified antithrombin III-containing supernate from step (c) is (d) treated with an additional amount of an ethylene oxide-propylene oxide block copolymer or polyethylene glycol protein precipitating agent to precipitate the antithrombin III therefrom.
Claim 4
Dependent Claim
48 words
The process of claim 1, wherein the plasma fraction treated in step (a) is prepared by admixing a plasma fraction which is substantially free of fibrinogen and Factor VIII with tricalcium phosphate to precipitate prothrombin complex therefrom, and treating the resulting supernate as set forth in step (a).
Claim 5
Dependent Claim
49 words
The process of claim 1, wherein the plasma fraction treated in step (a) is prepared by (i) dissolving a Cohn plasma Fraction IV and (ii) admixing the resulting solution with tricalcium phosphate to precipitate prothrombin complex therefrom, prior to treating the resulting supernate as set forth in step (a).
References Cited (Backward Citations)
US3631018A
Cited
US3682881A
Cited
US3770631A
Cited
US3839314A
Cited
US3842061A
Cited
US3880989A
Cited
US3956259A
Cited
US3850903A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-05-01 | 1981-10-31 | 1982-05-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-05-01 | 1985-10-31 | 1986-05-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-05-01 | 1989-10-31 | 1990-05-02 | $7700.00 | Window Closed / Lapsed |